Creatine deficiency syndromes

Inborn Metabolic Diseases: Diagnosis and Treatment

Volumn , Issue , 2012, Pages 239-247

  Stockler Ipsiroglu, Sylvia ^a   Mercimek Mahmutoglu, Saadet ^a   Salomons, Gajja S ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956691135     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-15720-2_16     Document Type: Chapter

References (65)

1. Mercimek-Mahmutoglu S, Stockler-Ipsiroglu S (Updated 2009) Creatine deficiency syndromes. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle. 1997-2011. Available at http://www.genetests.org
2. Stockler S, Schutz PW, Salomons GS (2007) Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell Biochem 46:149-166
3. Stockler S, Holzbach U, Hanefeld F et al. (1994) Creatine deficiency in the brain: a new treatable inborn error of metabolism. Pediatr Res 36:409-413
4. Stockler S, Isbrandt D, Hanefeld F et al. (1996) Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am J Hum Genet 58:914-922
5. Mercimek-Mahmutoglu S, Stockler-Ipsiroglu S, Adami A et al. (2006) Clinical, biochemical and molecular features of guanidinoacetate methyltransferase deficiency. Neurology 67:480-484
6. Dhar SU, Scaglia F, Li FY, Smith L et al. (2009) Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency. Mol Genet Metab 96:38-43
7. Morris AA, Appleton RE, Power B et al. (2007) Guanidinoacetate methyltransferase deficiency masquerading as a mitochondrial encephalopathy. J Inherit Metab Dis 30:100
8. O’Rourke DJ, Ryan S, Salomons G et al. (2009) Guanidinoacetate methyltransferase (GAMT) deficiency: late onset of movement disorder and preserved expressive language. Dev Med Child Neurol 51:404-407
9. Bianchi MC, Tosetti M, Fornai F et al. (2002) Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann Neurol 47: 511-513
10. Item CB, Stockler-Ipsiroglu S, Stromberger C et al. (2001) Arginine:glycine amindinotransferase (AGAT) deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet 69:1127-1133
11. Battini R, Leuzzi V, Carducci C et al. (2002) Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree. Mol Genet Metab 77:326-331
12. Battini R, Alessandri MG, Leuzzi V et al. i (2006) Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: early treatment can prevent phenotypic expression of the disease. J Pediatr 148:828-830
13. Johnston K, Plawner L, Cooper L et al. (2005) The second family with AGAT deficiency (creatine biosynthesis defect): diagnosis, treatment and the first prenatal diagnosis (abstract). In: Proceedings of the Annual Meeting of the American Society of Human Genetics, Salt Lake City, Utah, p 58
14. Edvardson S, Korman SH, Livne A et al. (2010) l-Arginine:glycine amidinotransferase (AGAT) deficiency: clinical presentation and response to treatment in two patients with a novel mutation. Mol Genet Metab 101:228-32
15. Salomons GS, Dooren v SJ, Verhoeven NM et al. (2001) X-Linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 68:1497-1500
16. Cecil KM, Salomons GS, Ball WS Jr et al. (2001) Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol 49:401-404
17. Betsalel OT, Rosenberg EH, Almeida LS et al. (2011) Characterization of novel SLC6A8 variants with the use of splice-site analysis tools and implementation of a newly developed LOVD database. Eur J Hum Genet 19:56-63
18. DeGrauw TJ, Salomons GS, Cecil KM et al. (2002) Congenital creatine transporter deficiency. Neuropediatrics 33:232-238
19. DeGrauw TJ, Cecil KM, Byars AW et al. (2003) The clinical syndrome of creatine transporter deficiency. Mol Cell Biochem 244:45-48
20. Mancini GM, Catsman-Berrevoets CE, de Coo IF et al. (2004) Two novel mutations in SLC6A8 cause creatine transporter defect and distinctive X-linked mental retardation in two unrelated Dutch families. Am J Med Genet 132:288-295
21. Hahn KA, Salomons GS, Tackels-Horne D et al. (2002) X-Linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am J Hum Genet 70:1349-1356
22. Kleefstra T, Rosenberg EH, Salomons GS et al. (2005) Progressive intestinal, neurological and psychiatric problems in two adult males with cerebral creatine deficiency caused by an SLC6A8 mutation. Clin Genet 68:379-381
23. Anselm IA, Coulter DL, Darras BT (2008) Cardiac manifestations in a child with a novel mutation in creatine transporter gene SLC6A8. Neurology 29/70:1642-1644
24. Fons C, Sempere A, Sanmarti FX et al. (2009) Epilepsy spectrum in cerebral creatine transporter deficiency. Epilepsia 50:2168-2170
25. Mancardi MM, Caruso U, Schiaffino MC et al. (2007) Severe epilepsy in X-linked creatine transporter defect (CRTR-D). Epilepsia 48:1211-1213
26. Mercimek-Mahmutoglu S, Connolly MB, Poskitt K et al. (2010) Treatment of intractable epilepsy in a female with SLC6A8 deficiency. Mol Genet Metab 101:409-12
27. Kamp v d JM, Mancini GM, Pouwels PJ et al. (2011) Clinical features and X-inactivation in females heterozygous for creatine transporter defect. Clin Genet 79:264-72
28. Rosenberg EH, Almeida LS, Kleefstra T et al. (2004) High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet 75:97-105
29. Newmeyer A, Cecil KM, Schapiro M, Clark JF, Degrauw TJ (2005) Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging. J Dev Behav Pediatr 26:276-282
30. Clark AJ, Rosenberg EH, Almeida LS et al. (2006) X-Linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology. Hum Genet 119:604-610
31. Lion-Francois L, Cheillan D, Pitelet G et al. (2006) High frequency of creatine deficiency syndromes in patients with unexplained mental retardation. Neurology 67:1713-1714
32. Arias A, Corbella M, Fons C et al. (2007) Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening. Clin Biochem 40:1328-1331
33. Almeida LS, Salomons GS, Hogenboom F, Jakobs C, Schoffelmeer AN (2006) Exocytotic release of creatine in rat brain. Synapse 60:118-123
34. Schulze A, Bachert P, Schlemmer H et al. (2003) Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol 53:248-251
35. Ensenauer R, Thiel T, Schwab KO et al. (2004) Guanidinoacetate methyltransferase deficiency: differences of creatine uptake in human brain and muscle. Mol Genet Metab 82:208-213
36. Almeida LS, Verhoeven NM, Roos B et al. (2004) Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol Genet Metab 82:214-219
37. Stockler-Ipsiroglu S, Stromberger C, Item CB et al. (2003) In: Blau N, Duran M, Blaskovics ME, Gibson KM (eds). Physician’s guide to the laboratory diagnosis of metabolic diseases. Springer, Heidelberg Berlin New York, pp 467-480
38. Spronsen v FJ, Reijngoud DJ, Verhoeven NM et al. (2006) High cerebral guanidinoacetate and variable creatine concentrations in argininosuccinate synthetase and lyase deficiency: implications for treatment. Mol Genet Metab 89:274-276
39. Nanto-Salonen K, Komu M, Lundbom N et al. (1999) Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology 53:303-307
40. Bodamer OA, Sahoo T, Beaudet AL et al. (2005) Creatine metabolism in combined methylmalonic aciduria and homocystinuria. Ann Neurol 57:557-560
41. Betsalel OT, Kamp v d JM, Martinez-Munoz C et al. (2008) Detection of low-level somatic and germline mosaicism by denaturing high-performance liquid chromatography in a EURO-MRX family with SLC6A8 deficiency. Neurogenetics 9:183-190
42. Salomons GS, Dooren v SJ, Verhoeven NM et al. (2003) X-Linked creatine transporter defect: an overview. J Inherit Metab Dis 26:309-318
43. Almeida LS, Vilarinho L, Darmin PS et al. (2007) A prevalent pathogenic GAMT mutation (c.59G>C) in Portugal. Mol Genet Metab 91:1-6
44. Arias A, Ormazabal A, Moreno J et al. (2006) Methods for the diagnosis of creatine deficiency syndromes: a comparative study. J Neurosci Methods 156:305-309
45. Young S, Struys E, Wood T (2007) Quantification of creatine and guanidinoacetate using GC-MS and LC-MS/MS for the detection of cerebral creatine deficiency syndromes. Curr Protoc Hum Genet, chap 17, Unit 17.3
46. Carling RS, Hogg SL, Wood TC, Calvin J (2008) Simultaneous determination of guanidinoacetate, creatine and creatinine in urine and plasma by un-derivatized liquid chromatography-tandem mass spectrometry. Ann Clin Biochem 45:575-584
47. Mercimek-Mahmutoglu S, Muehl A, Salomons GS et al. (2009) Screening for X-linked creatine transporter (SLC6A8) deficiency via simultaneous determination of urinary creatine to creatinine ratio by tandem mass-spectrometry. Mol Genet Metab 96:273-275
48. Valongo C, Cardoso ML, Domingues P et al. (2004) Age related reference values for urine creatine and guanidinoacetic acid concentration in children and adolescents by gas chromatographymass spectrometry. Clin Chim Acta 348:155-161
49. Bodamer OA, Bloesch SM, Gregg AR, Stockler-Ipsiroglu S, O’Brien WE (2001) Analysis of guanidinoacetate and creatine by isotope dilution electrospray tandem mass spectrometry. Clin Chim Acta 308:173-178
50. Carducci C, Santagata S, Leuzzi V et al. (2006) Quantitative determination of guanidinoacetate and creatine in dried blood spot by flow injection analysis-electrospray tandem mass spectrometry. Clin Chim Acta 364:180-187
51. Item CB, Mercimek-Mahmutoglu S, Battini R et al. (2004) Characterization of seven novel mutations in seven patients with GAMT deficiency. Hum Mutat 23:524
52. Item CB, Stockler-Ipsiroglu S, Willheim C, Muhl A, Bodamer OA (2005) Use of denaturing HPLC to provide efficient detection of mutations causing guanidinoacetate methyltransferase deficiency. Mol Genet Metab 86:328-334
53. Verhoeven NM, Schor DS, Roos B et al. (2003) Diagnostic enzyme assay that uses stable-isotope-labeled substrates to detect l-arginine:glycine amidinotransferase deficiency. Clin Chem 49:803-805
54. Verhoeven NM, Roos B, Struys EA et al. (2004) Enzyme assay for diagnosis of guanidinoacetate methyltransferase deficiency. Clin Chem 50:441-443
55. Rosenberg EH, Martinez Munoz C, Betsalel OT et al. (2007) Functional characterization of missense variants in the creatine transporter gene (SLC6A8): improved diagnostic application. Hum Mutat 28:890-896
56. Cheillan D, Salomons GS, Acquaviva C et al. (2006) Prenatal diagnosis of guanidinoacetate methyltransferase deficiency: increased guanidinoacetate concentrations in amniotic fluid. Clin Chem 52:775-777
57. Stockler S, Hanefeld F, Frahm J (1996) Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 348: 789-790
58. Schulze A, Ebinger F, Rating D, Mayatepek E (2001) Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 74:413-419
59. Stockler-Ipsiroglu S, Battini R, de Grauw T, Schulze A (2005) Disorders of creatine metabolism. In: Blau N, Hoffmann GF, Leonard J, Clarke JTR (eds) Physician’s guide to the treatment and follow up of metabolic diseases. Springer-Verlag, Heidelberg, Berlin New York, pp 255-265
60. Stockler S, Marescau B, De Deyn PP et al. (1997) Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis. Metabolism 46:1189-1193
61. Schulze A, Hoffmann GF, Bachert P et al. (2006) Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology 67:719-721
62. Sweetman L, Ashcraft P (2010) Newborn screening for GAMT deficiency: experience with guanidinoacetate by FIA-MS/MS and UPLC-MS/MS second tier testing. J Inherit Metab Dis 33 [Suppl 1]:S98
63. Braissant O, Bachmann C, Henry H (2007) Expression and function of AGAT, GAMT and CT1 in the mammalian brain. Subcell Biochem 46:67-81
64. Chilosi A, Leuzzi V, Battini R et al. (2008) Treatment with l-arginine improves neuropsychological disorders in a child with creatine transporter defect. Neurocase 14:151-161
65. Fons C, Sempere A, Arias A et al. (2008) Arginine supplementation in four patients with X-linked creatine transporter defect. J Inherit Metab Dis 31:724-728